Explore >> Select a destination

You are here

 www.yalemedicine.org
FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease > News > Yale Medicine
| | diggz.me
It's "World Liver Day": Top 5 Causes of Liver Disease - Diggz.Me
6.7 parsecs away

Travel
| | Mark World Liver Day by understanding the leading causes of liver disease. Learn about the top five risks that can compromise liver health and the crucial steps for prevention.
| | keepkidshealthy.com
Oral Antiviral COVID Treatments - Keep Kids Healthy
10.6 parsecs away

Travel
| | Paxlovid and Molnupiravir are two new oral antiviral COVID treatments that were recently authorized.
| | theprint.in
New treatment discovered for rare eye disease may prevent blindness ThePrint ANIFeed
9.2 parsecs away

Travel
| | Washington [US], December 19 (ANI): Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine. The randomized, double-blind, placebo-controlled trial was conducted by the department []
| | brighterworld.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - Brighter World
37.3 parsecs away

Travel
| Update, March 3, 2022: Human clinical trials for these vaccines have begun and are ongoing. This story was originally published on Dec. 7, 2021. Human . . .